Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dietary Supplement Enforcement Procedure Streamlining Planned By CFSAN

This article was originally published in The Tan Sheet

Executive Summary

Consolidating FDA's enforcement process with regard to inappropriate dietary supplement claims is one of the Center for Food Safety & Applied Nutrition's "A-list" goals for 2000.

You may also be interested in...



CFSAN Supplement "Disease Claims" Enforcement Authority Spelled Out

FDA's Center for Food Safety & Applied Nutrition has lead responsibility for issuing warning letter drug charges for dietary supplements bearing "disease claims," under an April 6 intercenter agreement with the Center for Drug Evaluation & Research.

CFSAN Supplement "Disease Claims" Enforcement Authority Spelled Out

FDA's Center for Food Safety & Applied Nutrition has lead responsibility for issuing warning letter drug charges for dietary supplements bearing "disease claims," under an April 6 intercenter agreement with the Center for Drug Evaluation & Research.

CFSAN Supplement "Disease Claims" Enforcement Authority Spelled Out

FDA's Center for Food Safety & Applied Nutrition has lead responsibility for issuing warning letter drug charges for dietary supplements bearing "disease claims," under an April 6 intercenter agreement with the Center for Drug Evaluation & Research.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090855

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel